Business Description
Novavax Inc
NAICS : 325414
SIC : 2836
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.5 | |||||
Equity-to-Asset | -0.24 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -1.02 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -3.3 | |||||
Beneish M-Score | -4.61 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 142.1 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | -65.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.06 | |||||
9-Day RSI | 38.95 | |||||
14-Day RSI | 40.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.91 | |||||
Days Inventory | 32.45 | |||||
Days Sales Outstanding | 80.86 | |||||
Days Payable | 93.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.3 | |||||
Shareholder Yield % | -27.03 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.21 | |||||
Operating Margin % | -37.34 | |||||
Net Margin % | -37.5 | |||||
FCF Margin % | -2.66 | |||||
ROA % | -17.71 | |||||
ROIC % | -19.19 | |||||
3-Year ROIIC % | -14.14 | |||||
ROC (Joel Greenblatt) % | -59.26 | |||||
ROCE % | -82.94 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.87 | |||||
EV-to-EBIT | -2.89 | |||||
EV-to-EBITDA | -3.47 | |||||
EV-to-Revenue | 1.01 | |||||
EV-to-FCF | -34.99 | |||||
Price-to-Median-PS-Value | 0.11 | |||||
Earnings Yield (Greenblatt) % | -34.56 | |||||
FCF Yield % | -1.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Novavax Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 725.373 | ||
EPS (TTM) (€) | -2.575 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 40.2 | ||
14-Day ATR (€) | 0.494646 | ||
20-Day SMA (€) | 10.69845 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 9.022 - 13.35 | ||
Shares Outstanding (Mil) | 160.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Novavax Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Novavax Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Novavax Inc Frequently Asked Questions
What is Novavax Inc(WBO:NVAX)'s stock price today?
When is next earnings date of Novavax Inc(WBO:NVAX)?
Does Novavax Inc(WBO:NVAX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |